| Literature DB >> 31938457 |
Max Keller1, Shahani A Mahuroof2, Vivyanne Hong Yee2, Jessica Carpenter2, Lisa Schindler1, Timo Littmann1, Andrea Pegoli1, Harald Hübner3, Günther Bernhardt1, Peter Gmeiner3, Nicholas D Holliday2.
Abstract
Fluorescence-labeled receptor ligands have emerged as valuable molecular tools, being indispensable for studying receptor-ligand interactions by fluorescence-based techniques such as high-content imaging, fluorescence microscopy, and fluorescence polarization. Through application of a new labeling strategy for peptides, a series of fluorescent neurotensin(8-13) derivatives was synthesized by attaching red-emitting fluorophores (indolinium- and pyridinium-type cyanine dyes) to carbamoylated arginine residues in neurotensin(8-13) analogues, yielding fluorescent probes with high NTS1R affinity (pK i values: 8.15-9.12) and potency (pEC50 values (Ca2+ mobilization): 8.23-9.43). Selected fluorescent ligands were investigated by flow cytometry and high-content imaging (saturation binding, kinetic studies, and competition binding) as well as by confocal microscopy using intact CHO-hNTS1R cells. The study demonstrates the applicability of the fluorescent probes as molecular tools to obtain, for example, information about the localization of receptors in cells and to determine binding affinities of nonlabeled ligands.Entities:
Year: 2019 PMID: 31938457 PMCID: PMC6956362 DOI: 10.1021/acsmedchemlett.9b00462
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345
Figure 1Structures of the tridecapeptide neurotensin, NT(8–13) (1, blue), the radiolabeled NT(8–13) derivative [3H]2,[19] and the fluorescent NT(8–13) derivative 3.[19]Granier et al.[20]Einsiedel et al.[21]Keller et al.[19]
Scheme 1Synthesis of the Fluorescent NT(8–13) Derivatives 6, 9, 11, 12, 14, 16, and 17 as well as the Fluorescent “Dummy Ligands” 19 and 20
Reagents and conditions: (a) DIPEA, DMF, NMP, rt, 30 min, 42% (6), 27% (11), 38% (12), 24% (16), 42% (17); (b) DIPEA, KHCO3, DMF, H2O, rt, 30 min, 26%; (c) triethylamine, DMF, NMP, rt, 2 h, 25%; (d) DIPEA, DMF, rt, 15 min, 27% (19), 64% (20).
Figure 2Structures of the synthesized and investigated fluorescent NT(8–13) derivatives 3,[19]6, 9, 11, 12, 14, 16, and 17 as well as structures of the fluorescent “dummy ligands” 19, 20, and 21.[19]
NTS1R Binding Data (pKi) of 1, 3, 6, 9, 11, 12, 14, 16, and 17, NTS2R Binding Data (pKi) of 1, 3, 6, 9, 12, and 17, pKd Values of 3, 6, 9, and 12 Determined by Saturation Binding (hNTS1R), and hNTS1R Potencies (pEC50) of 1, 3, 6, and 12 from Ca2+ Assays
| hNTS1R | hNTS2R | |||||||
|---|---|---|---|---|---|---|---|---|
| compound | p | p | p | p | pEC50 | p | ||
| 60 min/no wash | 75 min/with wash | |||||||
| 9.89 ± 0.01 | n.d. | n.a. | n.a. | n.a. | 8.92 ± 0.12 | 10.16 ± 0.14 | 9.13 ± 0.07 | |
| 8.38 ± 0.02 | 8.15 ± 0.03 | 8.44 ± 0.01 | 7.82 ± 0.16 | 8.09 ± 0.04 | 8.99 ± 0.07 | n.d. | 8.92 ± 0.15 | |
| 8.86 ± 0.05 | 8.88 ± 0.12 | 8.41 ± 0.1 | 8.20 ± 0.07 | 8.42 ± 0.21 | 8.23 ± 0.07 | 9.38 ± 0.22 | 8.40 ± 0.05 | |
| 8.66 ± 0.01 | 8.61 ± 0.08 | n.d. | 7.99 ± 0.14 | 8.61 ± 0.29 | n.d. | n.d. | 9.02 ± 0.06 | |
| 8.37 ± 0.07 | 8.60 ± 0.05 | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | |
| 8.70 ± 0.05 | 8.81 ± 0.03 | n.d. | 7.59 ± 0.10 | 8.17 ± 0.22 | n.d. | 9.43 ± 0.23 | 8.46 ± 0.14 | |
| 9.12 ± 0.03 | 8.89 ± 0.09 | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | |
| 8.57 ± 0.002 | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | 8.14 ± 0.02 | |
| 8.45 ± 0.02 | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | |
Determined by radioligand competition binding with [3H]2 at HT-29 colon carcinoma cells (Kd ([3H]2) = 0.55 nM); mean values ± SEM from two (16), three (3, 6, 9, 11, 12, 17), or four (14) independent experiments (performed in triplicate).
Determined by radioligand competition binding with [3H]2 at CHO-hNTS1R cells (Kd ([3H]2) = 0.29 nM); mean values ± SEM from three independent experiments (performed in triplicate).
Determined by flow cytometric saturation binding at CHO-hNTS1R cells using PBS as binding buffer; mean values ± SEM from two (3) or four (6) independent experiments (performed in duplicate).
Determined by high-content imaging saturation binding at CHO-hNTS1R cells (binding buffer: Leibovitz’s L15 medium, incubation period: 60 or 75 min); “no wash” indicates that no washing step was performed before the measurement, “with wash” indicates that one washing step was performed shortly before the measurement; mean values ± SEM from four (3, 6, 9) or five (12) (60 min incubation), and three (9), four (3) or five (6, 12) (75 min incubation) independent experiments (performed in triplicate).
Determined in a Fura-2 Ca2+ assay at human HT-29 cells; mean values ± SEM from two (1) or three (3, 6) independent experiments (performed in singlet).
Determined in a Fluo-4 Ca2+ assay at CHO-hNTS1R cells; mean values ± SEM from eight independent experiments (performed in triplicate).
Determined by competition binding with [3H]2 at HEK-hNTS2R cell homogenates (Kd ([3H]2) = 0.79 nM); mean values ± SEM from three (3, 6, 9), four (16), five (12), or seven (1) independent experiments (performed in triplicate).
Data were previously reported as Ki value by Keller et al. and were reanalyzed to give the pKi value.[19] n.d.: not determined; n.a.: not applicable
Figure 3Binding of the cyanine dye labeled fluorescent peptides 3 (fluorophore with positive net charge) (panel A), 6 (fluorophore with negative net charge) (panel B), and 11 (fluorophore with no net charge) (panel C) as well as the pyridinium dye labeled ligand 14 (fluorophore with positive net charge) (panel D) to live CHO-hNTS1R cells at 22–25 °C at the given concentrations, investigated by confocal microscopy (3, 6, and 11: excitation 633 nm, emission LP 650, 14: excitation 488 nm, emission LP 560). Images (representative of at least two experiments) were acquired with a LSM 510 confocal microscope after incubation times of 5, 15, 30, and 45 min. Unspecific binding was determined in the presence of 1 (100-fold excess to the fluorescent peptide).